Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn2r22 Inhibitors

Vmn2r22 inhibitors belong to a specific class of chemical agents that target a subset of receptors within the vast olfactory receptor family. The Vmn2r22 receptor is a part of the vomeronasal type-2 receptor (V2R) family, which plays a role in the detection of pheromonal signals. These receptors are distinct from the more commonly known olfactory receptors that detect general odors; they are specialized and tuned to pick up on chemical communication cues in many animals. Inhibitors of Vmn2r22 are designed to selectively bind to these receptors and block their normal function, thereby preventing the receptor from activating its downstream signaling pathways. The precise molecular structure of these inhibitors is crafted to fit into the binding site of the Vmn2r22 receptor, which is typically a G protein-coupled receptor (GPCR), a class known for its significance in cellular communication processes.

The development and study of Vmn2r22 inhibitors mainly hinge on the intricate understanding of the receptor's structure and the signaling mechanisms it employs. These receptors are embedded within the membrane of the specialized sensory neurons located in the vomeronasal organ (VNO), which is part of the accessory olfactory system present in some mammals. The inhibition mechanism involves the compound interacting with the receptor in a way that prevents the normal ligand (such as a pheromone) from binding, or it may involve the inhibitor binding to the receptor without activating it, acting as an antagonist. This interaction typically requires a high degree of specificity and affinity for the Vmn2r22 receptor to ensure that other receptors are not affected, which would result in off-target effects. Research into these chemical inhibitors is driven by a profound interest in the fundamental aspects of molecular recognition and signal transduction, as well as the desire to understand how animals, including humans, perceive and respond to their chemical environment at the most basic level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Copper(II) sulfate

7758-98-7sc-211133
sc-211133A
sc-211133B
100 g
500 g
1 kg
$46.00
$122.00
$189.00
3
(1)

Copper ions can act as allosteric modulators for various proteins. If Vmn2r22's activity is modulated by copper-binding sites, copper sulfate could potentially alter its conformation, and thus inhibit its sensory function.

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Similar to copper, zinc ions can bind to and inhibit various proteins. If Vmn2r22 has a zinc-binding site that is critical for its activation or signaling, zinc sulfate could inhibit its functional activity.

SQ 22536

17318-31-9sc-201572
sc-201572A
5 mg
25 mg
$95.00
$363.00
13
(1)

By inhibiting adenylate cyclase, SQ 22536 would reduce cAMP levels, a secondary messenger commonly involved in G-protein-coupled receptor signaling. If Vmn2r22 signals through a G-protein that activates adenylate cyclase, this inhibition could indirectly decrease its activity.

Chelerythrine

34316-15-9sc-507380
100 mg
$540.00
(0)

Chelerythrine is an inhibitor of Protein Kinase C (PKC), which may phosphorylate proteins downstream of Vmn2r22. Inhibition of PKC could thus decrease Vmn2r22-mediated signaling if PKC is part of its signaling cascade.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Verapamil blocks voltage-dependent L-type calcium channels. If Vmn2r22 signaling is calcium-dependent, either through direct ion flux or modulation of downstream targets, Verapamil could indirectly inhibit Vmn2r22 activity.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Rho kinase is involved in actin cytoskeleton organization. If Vmn2r22 signaling involves cytoskeletal rearrangement, inhibition by Y-27632 could lead to decreased Vmn2r22 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits phosphatidylinositol 3-kinase, which is involved in the Akt signaling pathway. If Vmn2r22 activity is linked to PI3K/Akt signaling, inhibition by LY294002 could result in decreased Vmn2r22 function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a specific inhibitor of MEK, which acts upstream in the MAPK/ERK pathway. If Vmn2r22 exerts its effects through this pathway, inhibition by PD98059 could reduce Vmn2r22-mediated signaling.